Allan Levey, PhD
Neurology · Atlanta, GANPI 1740398494
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,375 of the $12,549 with a category attached, or 98.6%. Biogen accounts for 67.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $9,550 and has fallen 98.2% since, to $174 in 2022.
Across 8 payments — averaging $1568.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$8K
- Novo Nordisk$4K
- Lilly USA, LLC$144
- Eisai Inc.$30
Across 428 payments — averaging $9669.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$2M
- Eisai Inc.$975K
- Novartis$483K
- Roche Diagnostics Corporation$357K
- Genentech, Inc.$351K
- Eli Lilly$11K
- plus $9K from 2 others
What the payments were for
- Consulting fees$12,37599%
- Food & beverage$1441%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 3 | $8,475 |
| Novo Nordisk | 2 | $3,900 |
| Lilly USA, LLC | 2 | $144 |
| Eisai Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,549 in reported general payments places this provider in the 75th percentile of 506 neurology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Atlanta
- Joash LazarusAtlanta$1.1M
- Jeffrey EnglishAtlanta$749K
- Frank BerensonAtlanta$527K
- Julio FlaminiAtlanta$501K
- Douglas StuartAtlanta$493K
- Robert GilbertAtlanta$412K
- Lawrence SeidenAtlanta$272K
- Jacqueline RosenthalAtlanta$241K
- Ben ThrowerAtlanta$203K
- Jaime Hatcher MartinAtlanta$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.